A Journal of Analytical Chemistry and Chemical Analysis

Yazarlar: Bárbara Rienda, Ane Elexpe, Tarson Tolentino-Cortez, Marina Gulak, Cristina Bruzos-Cidón, María Torrecilla, Egoitz Astigarraga, Gabriel Barreda-Gómez

Konular:-

DOI:10.3390/analytica2010003

Anahtar Kelimeler:Acetylcholinesterase,Microarray,Inhibitors,Alzheimer’s disease

Özet: Acetylcholinesterase (AChE) is responsible for hydrolyzing the acetylcholine neurotransmitter, bringing an end point to cholinergic neurotransmission. Thus, AChE is the primary target of a wide spectrum of compounds used as pesticides, nerve agents or therapeutic drugs for neurodegenerative diseases such as Alzheimer’s disease (AD). This enzyme is heterogeneously distributed in the brain showing different activity depending on the nervous region. Therefore, the aim of this work is to report a novel technology that enables the simultaneous determination of tissue specific AChE activity, as well as the analysis and screening of specific inhibitors, by using cell membrane microarrays. These microarrays were composed of cell membranes, isolated from 41 tissues, organs and brain areas, that were immobilized over a slide, maintaining the functionality of membrane proteins. To validate this platform, demonstrating its usefulness in drug discovery as a high throughput screening tool, a colorimetric protocol to detect the membrane-bound AChE activity was optimized. Thus, rat cortical and striatal AChE activities were estimated in presence of increased concentrations of AChE inhibitors, and the donepezil effect was assessed simultaneously in 41 tissues and organs, demonstrating the major potential of this microarray’s technology.

---